Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA STRIDES PHARMA SCIENCE ABBOTT INDIA/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 50.0 -1,455.3 - View Chart
P/BV x 18.2 3.3 554.9% View Chart
Dividend Yield % 1.2 0.2 629.3%  

Financials

 ABBOTT INDIA   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-23
STRIDES PHARMA SCIENCE
Mar-23
ABBOTT INDIA/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs22,482392 5,732.2%   
Low Rs16,156263 6,132.5%   
Sales per share (Unadj.) Rs2,517.0408.5 616.2%  
Earnings per share (Unadj.) Rs446.8-25.6 -1,747.3%  
Cash flow per share (Unadj.) Rs479.71.4 35,066.5%  
Dividends per share (Unadj.) Rs325.001.50 21,666.7%  
Avg Dividend yield %1.70.5 367.7%  
Book value per share (Unadj.) Rs1,480.5242.8 609.7%  
Shares outstanding (eoy) m21.2590.30 23.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.70.8 956.2%   
Avg P/E ratio x43.2-12.8 -337.3%  
P/CF ratio (eoy) x40.3239.6 16.8%  
Price / Book Value ratio x13.01.4 966.6%  
Dividend payout %72.7-5.9 -1,239.9%   
Avg Mkt Cap Rs m410,51329,603 1,386.7%   
No. of employees `000NANA-   
Total wages/salary Rs m5,6367,320 77.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,48736,884 145.0%  
Other income Rs m1,5431,352 114.1%   
Total revenues Rs m55,03038,236 143.9%   
Gross profit Rs m12,055830 1,452.8%  
Depreciation Rs m7002,433 28.8%   
Interest Rs m1602,611 6.1%   
Profit before tax Rs m12,738-2,862 -445.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,244-553 -586.6%   
Profit after tax Rs m9,494-2,309 -411.2%  
Gross profit margin %22.52.2 1,001.8%  
Effective tax rate %25.519.3 131.8%   
Net profit margin %17.8-6.3 -283.5%  
BALANCE SHEET DATA
Current assets Rs m30,25131,353 96.5%   
Current liabilities Rs m12,06029,902 40.3%   
Net working cap to sales %34.03.9 864.8%  
Current ratio x2.51.0 239.2%  
Inventory Days Days8771 122.1%  
Debtors Days Days2129 1.7%  
Net fixed assets Rs m15,13531,300 48.4%   
Share capital Rs m213903 23.5%   
"Free" reserves Rs m31,24821,025 148.6%   
Net worth Rs m31,46021,928 143.5%   
Long term debt Rs m011,398 0.0%   
Total assets Rs m45,38663,734 71.2%  
Interest coverage x80.7-0.1 -84,063.5%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.6 203.6%   
Return on assets %21.30.5 4,482.6%  
Return on equity %30.2-10.5 -286.6%  
Return on capital %41.0-0.8 -5,452.6%  
Exports to sales %0.446.7 0.9%   
Imports to sales %10.80-   
Exports (fob) Rs m22117,213 1.3%   
Imports (cif) Rs m5,765NA-   
Fx inflow Rs m31018,113 1.7%   
Fx outflow Rs m5,818672 866.3%   
Net fx Rs m-5,50817,442 -31.6%   
CASH FLOW
From Operations Rs m8,934444 2,011.6%  
From Investments Rs m-1,4773,025 -48.8%  
From Financial Activity Rs m-6,387-2,139 298.6%  
Net Cashflow Rs m1,0701,328 80.6%  

Share Holding

Indian Promoters % 0.0 27.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 8.9 38.9 23.0%  
FIIs % 0.2 19.5 0.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 72.6 34.4%  
Shareholders   72,252 91,182 79.2%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Abbott India vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs STRIDES PHARMA SCIENCE Share Price Performance

Period Abbott India STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day 0.74% 1.16% 1.18%
1-Month -5.97% 0.35% -0.75%
1-Year 24.80% 176.88% 61.82%
3-Year CAGR 21.40% -3.35% 18.16%
5-Year CAGR 29.91% 10.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 325.0 per share. This amounted to a Dividend Payout ratio of 72.7%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of Abbott India, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.